Background and Objectives: Independent evidence on the longer-term performance of the Extend Bessel-optics intraocular lens remains limited. This study aimed to evaluate refractive and visual changes beyond the first postoperative year and to characterize binocular functional vision, defocus performance, and patient-reported outcomes 36–48 months after bilateral implantation. Materials and Methods: This ambispective, single-center case series included patients who had undergone bilateral implantation of the non-toric Extend IOL with emmetropic targets and had complete one-year postoperative data. One-year refraction and visual acuity data were retrieved retrospectively; eligible patients who had reached at least 36 months after surgery underwent prospective evaluation including refraction, visual acuity, defocus curves, pupillometry, VF-14, spectacle use, dysphotopsia, and satisfaction. Results: Of 37 patients in the source cohort, two lacked the required one-year postoperative visit. All 35 eligible patients (70 eyes) completed the prospective evaluation at 36–48 months. No statistically significant change in subjective spherical equivalent was detected (mean paired change, +0.029 D; 95% CI, −0.005 to +0.062 D; p = 0.114). Small statistically significant changes occurred in objective spherical equivalent (−0.052 D) and UDVA, UIVA, and UNVA (+0.009, +0.027, and +0.025 logMAR, respectively). Mean binocular defocus acuity remained ≤0.20 logMAR from +1.00 to −2.00 D, and the pooled monocular profile was compatible with a Partial-DOFi Extended functional classification. Mean VF-14 score was 98.9 ± 2.5; 94.3–97.1% of patients reported never using spectacles across viewing distances, and dysphotopsia was infrequent and predominantly mild. Conclusions: Subjective spherical equivalent showed no statistically significant change between one year and 36–48 months, whereas small statistically significant changes occurred in objective refraction and uncorrected visual acuity. Cross-sectional functional and patient-reported outcomes at 3–4 years were favorable in this selected cohort, which was characterized by relatively high implanted IOL powers.
No takes yet. Share an insight, caveat, or question.
Bianchi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: